Allchem Lifescience IPO Date, Review, Price, Allotment Details

Allchem Lifescience IPO open date is 2026 and the IPO will close on 2026. Allchem Lifescience IPO is a Bookbuilding IPO Issue. The company to raise around [.] crores via IPO that comprises fresh issue of ₹[.] crores and offer for sale up to equity shares with face value of ₹10 each.

Allchem Lifescience IPO price band is [.] per share. The retail quota is 35%, QIB is 50%, and HNI is 15%. Allchem Lifescience IPO to list on BSE, NSE on 2026. The allotment of Allchem Lifescience IPO date is 2026.

The company reported revenue of ₹138.07 crores in 2024 against ₹106.03 crores in 2023. The company reported profit of ₹23.41 crores in 2024 against profit of ₹17.99 crores in 2023. As per the financials the IPO investors should apply the IPO for a long term.

Allchem Lifescience IPO

Allchem Lifescience IPO Details

IPO Open Date2026
IPO Close Date2026
Face Value₹10 Per Equity Share
IPO Price Band₹[.] to ₹[.] Per Share
Issue SizeApprox ₹[.] Crores
Fresh IssueApprox ₹[.] Crores
Offer for Sale:Approx [.] Equity Shares
Issue TypeBook Building  Issue
IPO ListingBSE, NSE
DRHP Draft ProspectusPDF
RHP Draft ProspectusPDF

Allchem Lifescience IPO Review & Key Points

  • Review:

Allchem Lifescience IPO Market Lot

The Allchem Lifescience IPO minimum market lot is [.] shares with ₹[.] application amount. The retail investors can apply up-to 13 lots with [.] shares of ₹[.] amount.

ApplicationLot SizeSharesAmount
Retail Minimum₹-
Retail Maximum₹-
S-HNI Minimum₹-
S-HNI Maximum₹-
B-HNI Minimum₹-

IPO Reservation

Investor CategoryShare Offered-% Shares
Anchor Investor– Shares-%
QIB (Ex. Anchor)– Shares50%
NII Shares Offered– Shares15%
Retail Shares Offered– Shares35%

Allchem Lifescience IPO Anchor Investors

Anchor Bidding Date2026
Anchor Investors ListPDF
Shares OfferedShares
Anchor Size-Cr.
lock-in period end date 50% shares (30 Days)2026
lock-in period end date 50% shares (90 Days)2026

Allchem Lifescience IPO Dates

The Allchem Lifescience IPO date is 2026 and the close date is 2026. The Allchem Lifescience IPO allotment will be finalized on 2026 and the IPO listing on 2026.

IPO Open Date:2026
IPO Close Date:2026
Basis of Allotment:2026
Refunds:2026
Credit to Demat Account:2026
IPO Listing Date:2026
IPO Bidding Cut-off Time:2026 – 5 PM

Promoters and Holding Pattern

The promoters of the company are Bipin Patel, Manisha Bipin Patel, Kantilal Ramanlal Patel and Aditi Patel.

ParticularShares% Share
Promoter Holding Pre Issue100%
Promoter Holding Post Issue-%

Objects of the Issue & Utilisation of proceeds

PurposeCrores
Repayment or pre-payment, in full or in part, of certain of the outstanding borrowings availed by the Company.₹130.00
General Corporate Purpose₹-

About Allchem Lifescience IPO

To be updated soon

Allchem Lifescience IPO Company Financial Report

Amount ₹ in Crores

Period EndedRevenueExpensePATAssets
2022₹109.42₹88.97₹14.14₹124.02
2023₹106.03₹79.50₹17.99₹186.68
2024₹138.07₹105.77₹23.41₹224.65
Sep 2024₹78.53₹62.51₹10.89₹246.30

Allchem Lifescience IPO Valuation – FY2024

Check Allchem Lifescience IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.

KPIValues
ROE:34.33%
ROCE:22.87%
EBITDA Margin:38.05%
PAT Margin:17.03%
Debt to equity ratio:1.31
Earning Per Share (EPS):₹3.06(Basic)
Price/Earning P/E Ratio:N/A
Return on Net Worth (RoNW):34.33%
Net Asset Value (NAV):₹10.44

Peer Group Comparison

CompanyEPSPE RatioRoNW %NAVIncome
Ami Organics Limited11.91182.096.92183.05701.37 Cr.
Aether Industries Limited6.74126.915.32156.09639.93 Cr.
Shree Ganesh Remedies Limited22.3531.4626.6595.05128.96 Cr.
Blue Jet Healthcare Limited9.4479.8721.4548.73740.46 Cr.

IPO Lead Managers aka Merchant Bankers

  • Emkay Global Financial Services Ltd.

Company Address

Allchem Lifescience Ltd.
Block No. 1088/B/P, 1088-A, Lamdapura Road,
Village Manjusar,
Tal-Savli
Vadodara, Gujarat, 391775
Phone: +91-9574722211
Email: investor@allchemlifescience.com
Website: https://www.allchemlifescience.com/

IPO Registrar

MUFG Intime India Pvt.Ltd.
Phone: +91-22-4918 6270
Email: allchemlifescience.ipo@in.mpms.mufg.com
Website: https://in.mpms.mufg.com/Initial_Offer/public-issues.html

Allchem Lifescience IPO FAQs

What is Allchem Lifescience IPO?

Allchem Lifescience IPO is Mainboard IPO. The company is going to raise ₹[.] Crores via IPO. The issue is priced at ₹[.] to ₹[.] per equity share. The IPO is to be listed on BSE & NSE.

When Allchem Lifescience IPO will open for subscription?

The IPO is to open on 2026 for QIB, NII, and Retail Investors. The IPO will close on 2026.

What is Allchem Lifescience IPO Investors Portion?

The investors’ portion for QIB is 50%, NII is 15%, and Retail is 35%.

How to Apply the Allchem Lifescience IPO?

You can apply for Allchem Lifescience IPO via ASBA online via your bank account. You can also apply for ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form.

What is Allchem Lifescience IPO Issue Size?

Allchem Lifescience IPO issue size is ₹[.] crores.

What is Allchem Lifescience IPO Price Band?

Allchem Lifescience IPO Price Band is ₹[.] to ₹[.].

What is Allchem Lifescience IPO Lot Size?

The minimum bid is [.] Shares with ₹[.] amount.

What is the Allchem Lifescience IPO Allotment Date?

Allchem Lifescience IPO allotment date is 2026.

What is the Allchem Lifescience IPO Listing Date?

Allchem Lifescience IPO listing date is 2026. The IPO is to list on BSE & NSE.

Note: The Allchem Lifescience IPO price band and date are officially announced. The (Allchem Lifescience IPO grey market premium) will be added to the IPO GMP page as it will start).

Table of Contents

Founder of IPOWatch, brings nearly 15 years of experience in IPO analysis and market research. He provides complete coverage of upcoming IPOs, subscription trends, grey market premiums (GMP), and post-listing performance, along with easy-to-understand reviews, insights, and analysis. In his working journey, he has worked with various platforms and received expertise in stock market analysis and primary markets.

Disclaimer: This content is provided strictly for educational and informational purposes. The securities or investments mentioned are not to be considered as investment advice or recommendations. The Investors are advised to do their own research or connect with a financial advisor before making any investment decisions.

Leave a Reply

Your email address will not be published. Required fields are marked *